Skip to main content
SpringerLink
Log in

New measures proposed to assess US drug costs

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Levy J, et al. A Transparent and Consistent Approach to Assess US Outpatient Drug Costs for Use in Cost-Effectiveness Analyses. Value in Health : 8 Sep 2017. Available from: URL: https://doi.org/10.1016/j.jval.2017.06.013

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

New measures proposed to assess US drug costs. PharmacoEcon Outcomes News 787, 29 (2017). https://doi.org/10.1007/s40274-017-4357-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4357-1

Search

Navigation